Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab
Public ClinicalTrials.gov record NCT00122304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety in Hemolytic PNH Patients Treated With Eculizumab: a Multi-Center Open-Label Research Design Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to evaluate the safety of eculizumab in patients with transfusion-dependent hemolytic PNH
Study identification
- NCT ID
- NCT00122304
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 85 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Nov 2006 (Type not available)
- Last update posted
- Feb 21, 2007
2004 – 2006
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Stanford University Medical Center, Division of Hematology | Stanford | California | 94305 | — |
| Hartford Hospital, Cancer Clinical Research Office | Hartford | Connecticut | 06102 | — |
| Cleveland Clinic Florida, Dept. of Clinical Research | Weston | Florida | 33331 | — |
| Indiana University Cancer Pavilion | Indianapolis | Indiana | 46202 | — |
| Johns Hopkins University Medical Center | Baltimore | Maryland | 21205 | — |
| National Heart, Lung, and Blood Institute, National Institutes of Health | Bethesda | Maryland | 20892 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Mayo Clinic, Division of Hematology | Rochester | Minnesota | 55905 | — |
| Washington University Medical Center, Department of Internal Medicine/Division of Hematology | St Louis | Missouri | 63110 | — |
| Cooper University Hospital, Cooper Cancer Institute | Voorhees Township | New Jersey | 08043 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| NYU Clinical Cancer Center | New York | New York | 10016 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10017 | — |
| Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program | Durham | North Carolina | 27710 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| OHSU Center for Hematologic Malignancies | Portland | Oregon | 97239 | — |
| Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thrombosis Program | Philadelphia | Pennsylvania | 19104 | — |
| University of Utah, Hematology-BMT Department | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00122304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2007 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00122304 live on ClinicalTrials.gov.